Key facts
- This page summarizes Ivan Tornos's Form 4 filing for ZIMMER BIOMET HOLDINGS, INC. (ZBH).
- 4 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 19 Feb 2025, 18:00.
Ivan Tornos - 14 Feb 2025 Form 4 Insider Report for ZIMMER BIOMET HOLDINGS, INC. (ZBH)
- Reporting relationship
- President and CEO, Director
- Issuer ticker
- ZBH
- Reported as of
- 14 Feb 2025
- Net transaction value
- -$1,295,426
- SEC form
- 4
- Accepted by SEC
- 19 Feb 2025, 18:00:26 UTC
- Prior SEC filing
- 08 Mar 2024
- Next SEC filing
- 24 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Matthew R. St. Louis, Attorney-in-Fact for Ivan Tornos (power of attorney previously filed)
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Ivan Tornos filed Form 4 for ZIMMER BIOMET HOLDINGS, INC. (ZBH) on 19 Feb 2025.
Change
- Previous filing in this sequence was filed on 08 Mar 2024.
- Current net transaction value: -$1,295,426.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ZBH
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +25,878
- Change %
- +96%
- Price
- $0.000000
- Shares after
- 52,840
- Date
- 18 Feb 2025
- Ownership
- Direct
- Footnotes
- F1
ZBH
transaction
Common Stock
Tax liability
- Transaction value
- $1,295,426
- Shares
- -12,826
- Change %
- -24%
- Price
- $101.00
- Shares after
- 40,014
- Date
- 18 Feb 2025
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ZBH
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +25,878
- Change %
- Price
- $0.000000
- Shares after
- 25,878
- Date
- 14 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 25,878
- Exercise price
- Footnotes
- F3, F4
ZBH
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -25,878
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 18 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 25,878
- Exercise price
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Includes 209 shares acquired under the Employee Stock Purchase Plan through February 18, 2025.
Footnote F2
Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").
Footnote F3
Each RSU represents a contingent right to receive one share of Company common stock.
Footnote F4
On February 18, 2022, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2022 - 2024. As determined on February 14, 2025, based on actual performance, the reporting person earned 25,878 RSUs, which vested on February 18, 2025.